BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1680660)

  • 1. Species-dependent stereopharmacokinetics of MK-927, a potent carbonic anhydrase inhibitor.
    Lin JH; Chen IW; Lin TH
    Drug Metab Dispos; 1991; 19(4):816-22. PubMed ID: 1680660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent stereopharmacokinetics of 5,6-dihydro-4H-4(isobutylamino)thieno(2,3-B)thiopyran-2-sulfonamide-7,7 -dioxide , a potent carbonic anhydrase inhibitor, in rats.
    Lin JH; Ulm EH; Los LE
    Drug Metab Dispos; 1991; 19(1):233-8. PubMed ID: 1673405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and stereoselective binding of the enantiomers of MK-927, a potent carbonic anhydrase inhibitor, by human erythrocytes in vitro.
    Lin JH; Lin TH; Cheng H
    Pharm Res; 1992 Mar; 9(3):339-44. PubMed ID: 1614967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interspecies differences in stereoselective protein binding and clearance of MK-571.
    Tocco DJ; deLuna FA; Duncan AE; Hsieh JH; Lin JH
    Drug Metab Dispos; 1990; 18(4):388-92. PubMed ID: 1976057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent pharmacokinetics of MK-417, a potent carbonic anhydrase inhibitor, in rabbits following single and multiple doses.
    Lin JH; Chen IW; Ulm EH; Gehret JR; Duggan DE
    Drug Metab Dispos; 1990; 18(6):836-41. PubMed ID: 1981525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear dorzolamide pharmacokinetics in rats: concentration-dependent erythrocyte distribution and drug-metabolite displacement interaction.
    Wong BK; Bruhin PJ; Barrish A; Lin JH
    Drug Metab Dispos; 1996 Jun; 24(6):659-63. PubMed ID: 8781782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent pharmacokinetics of MK-417, a potent carbonic anhydrase inhibitor, in experimental polycythemic and anemic rats.
    Lin JH; Chen IW; deLuna FA
    Pharm Res; 1991 May; 8(5):608-14. PubMed ID: 1866376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent pharmacokinetics of L-693,612, a carbonic anhydrase inhibitor, following oral administration in rats.
    Wong BK; Bruhin PJ; Lin JH
    Pharm Res; 1994 Mar; 11(3):438-41. PubMed ID: 8008713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-dependent enantioselective plasma protein binding of MK-571, a potent leukotriene D4 antagonist.
    Lin JH; deLuna FA; Ulm EH; Tocco DJ
    Drug Metab Dispos; 1990; 18(4):484-7. PubMed ID: 1976072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
    Hussein Z; Mulford DJ; Bopp BA; Granneman GR
    Drug Metab Dispos; 1993; 21(5):805-10. PubMed ID: 7902240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
    Cook CS; Karim A; Sollman P
    Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective pharmacokinetics of RS-8359, a selective and reversible MAO-A inhibitor, by species-dependent drug-metabolizing enzymes.
    Takasaki W; Yamamura M; Nozaki A; Nitanai T; Sasahara K; Itoh K; Tanaka Y
    Chirality; 2005 Mar; 17(3):135-41. PubMed ID: 15704197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
    Clay MP; Hanssen BR; Surapaneni SS; Lindstrom TD
    Chirality; 1999; 11(3):233-40. PubMed ID: 10079502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantiomer ratio of MK-0767 in humans and nonclinical species.
    Shen Z; Bakhtiar R; Komuro M; Awano K; Taga F; Colletti A; Hora D; Feeney W; Iliff S; Franklin RB; Vincent S
    Rapid Commun Mass Spectrom; 2005; 19(9):1125-9. PubMed ID: 15799073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro.
    Hasegawa T; Hara K; Hata S
    Drug Metab Dispos; 1994; 22(3):377-82. PubMed ID: 8070313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of direct stereoselective and non-stereoselective assays in biological fluids for the enantiomers of a thieno[2,3-b]thiopyran-2-sulfonamide, a topically effective carbonic anhydrase inhibitor.
    Matuszewski BK; Constanzer ML; Hessey GA; Bayne WF
    J Chromatogr; 1990 Apr; 526(2):461-73. PubMed ID: 2361985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective aspects in the pharmacokinetics and pharmacodynamics of acenocoumarol and its amino and acetamido derivatives in the rat.
    Thijssen HH; Baars LG; Drittij-Reijnders MJ
    Drug Metab Dispos; 1985; 13(5):593-7. PubMed ID: 2865109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective plasma protein binding and target tissue distribution of clausenamide enantiomers in rats.
    Zhu CJ; Zhang JT
    Chirality; 2009 Mar; 21(3):402-6. PubMed ID: 18655159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiospecific disposition of pranoprofen in beagle dogs and rats.
    Imai T; Nomura T; Aso M; Otagiri M
    Chirality; 2003 May; 15(4):312-7. PubMed ID: 12666237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.